It has been reported that 2–7% of lung adenocarcinomas (LuADs) have oncogenic ALK rearrangements, which cause the constitutive ligand-independent activation of ALK and the overexpression of the gene by fusing the intact kinase domain of ALK to the N-terminal regions of several different gene partners. Here, ALK is linked to lung adenocarcinoma.